UroGen Pharma (URGN) insider trading in the last 6 months

3 insiders sold $3.2M. No buys.

Quality Score1Below Average

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 5 tradesSee it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellChris Degnan$81KChief Financial Officerat $36.69 on Oct 8, filed Oct 9

SellChris DegnanChief Financial Officer$81Kat $36.69 on Oct 8, filed Oct 9

SellJason Drew Smith$65KGeneral Counselat $42.54 on Sep 8, filed Sep 9

SellJason Drew SmithGeneral Counsel$65Kat $42.54 on Sep 8, filed Sep 9

SellMark Schoenberg$37KChief Medical Officerat $42.92 on Sep 8, filed Sep 9

SellMark SchoenbergChief Medical Officer$37Kat $42.92 on Sep 8, filed Sep 9

From SEC Form 4s, the newest filed Oct 9, 2026 · Insiders have 2 business days to file a trade

Pro members see every filing on URGN with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at UroGen Pharma

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about URGN's insider trades

As of Nov 9, 2026: UroGen Pharma (URGN) has 5 insider filings on record in the last 6 months, the newest filed Oct 9, 2026. Its Quality Score is 1 (Below Average). Scores as of 9:05 AM ET, 15 minutes behind.

Are URGN insiders buying or selling?

3 insiders sold $3.2M across 5 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Chris Degnan, Chief Financial Officer, sold $81K on Oct 8, 2026.

Who are URGN's biggest insider sellers?

By the dollars of their sales in the last 6 months: Mark Schoenberg (Chief Medical Officer), 3 sales; Chris Degnan (Chief Financial Officer), 1 sale; Jason Drew Smith (General Counsel), 1 sale.

When did a URGN insider last buy?

No URGN insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Chris Degnan on Oct 8, 2026.

UroGen Pharma's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

UroGen Pharma (URGN) insider trading in the last 6 months

Form 4 filings, newest first

Who files at UroGen Pharma

Questions about URGN's insider trades

Every insider trade, with its stock's score.